Page last updated: 2024-10-30

ketotifen and Syndrome

ketotifen has been researched along with Syndrome in 2 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Syndrome: A characteristic symptom complex.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asawa, A1
Simpson, KH1
Bonds, RS1
Yamanaka, K1
Kuwashima, K1

Other Studies

2 other studies available for ketotifen and Syndrome

ArticleYear
Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2015, Volume: 114, Issue:6

    Topics: Adult; Anaphylaxis; Animals; Ant Venoms; Anti-Allergic Agents; Ants; Asthma; Erythema; Female; Hista

2015
[Effect of ketotifen fumarate for seizures in Lennox-Gastaut syndrome; a care report].
    No to hattatsu = Brain and development, 1999, Volume: 31, Issue:2

    Topics: Administration, Oral; Anti-Allergic Agents; Child; Dermatitis, Atopic; Epilepsy, Absence; Humans; Ke

1999